Reports by Industry
Reports by Company
- Company Analysis(173)
- Company Profile(60)
Pharmacogenomics: New Technologies in the Development of Personalized Therapies
Jul 25, 2006
The term ‘Pharmacogenomics’ is evolved from the words – pharmacology and genomics and therefore a combination of pharmaceuticals and genetics. Pharmacogenomics is a specialized study of how the genetic inheritance of an individual affects his body’s response to drugs. Being increasingly applied at the clinical level, its application is aimed on specific genes for therapeutics, and on screening genes for potential drug uses. It also aids pharmaceuticals in the development of highly sophisticated medications.
The application of pharmacogenomics is based on the combination of traditional pharmaceutical sciences such as biochemistry along with knowledge of genes, proteins, and single nucleotide polymorphisms. The present Pharmacogenomics market is comprised of three central segments, which are projected with a high growth rate. These are SNP identification technologies, genotyping technologies, and diagnostics.
The thrust of pharmacogenomics depends on the genome-wide analysis of the genetic characteristics of drug toxity and drug efficacy. This is a challenge to the ability to identify genetic variations also called polymorphisms that change a person’s reaction to a drug.
RNCOS in its market research report, “Bioinformatics Market Update (2006)” presents a compact analysis with respect to the current market for pharmacogenomics and its future propensity. Presently there has not been enough penetration in this area, thus leaving enormous scope for research and growth. This research report on Bioinformatics industry indicates particular interest in the markets for SNP Identification technologies, Genotyping technologies, and Diagnostics. Another area of interest is the market for selected drugs aided by the use of pharmacogenomics.
The report also states that the global bioinformatics market for pharmacogenomics reached $1.25Bn in 2004 and is estimated to jump to $4Bn by 2009 with an AAGR of 25%.
The report provides answers for some critical questions relating to –
- The current global outlook of Bioinformatics market;
- The recent developments in the Bioinformatics industry;
- The worldwide growth of the Genomics market;
- The driving forces of the Bioinformatics market;
- The opportunities for growth and impending threats for the industry; and
- Comparison between different companies in the Bioinformatics market.
The report is a useful guide for the pharmaceutical companies, IT firms, biotechnology firms, prospective investors, students and academicians in the field of bioinformatics.
For more information visit: http://www.rncos.com/Report/IM045.htm
Some of our Related Reports are as follows:Â
Related Releases are as follows:
Media Citation
- testtest
19 Jan, 2024 - Yourstory.com News @ Foodtech startup Swiggy launches Health Hub in Chennai
23 Mar, 2021 - Yourstory.com News @ Zomato forays into dietary supplements, makes its own 'made in India' brand
16 Mar, 2021 - View more
get in touch
Copyright © 2014, RNCOS, 2002-2014
About Us
Terms & Policy
Contact